Vaccines

26 Sep 2016 Sanaria® PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
22 Sep 2016 ASIT Biotech Announces the Initiation of a Phase 2a Clinical Study of Its Second Product Candidate hdm-ASIT+TM for House Dust Mite Rhinitis
22 Sep 2016 Aimmune Therapeutics Completes and Exceeds North American Enrollment Target Ahead of Schedule in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy; Company Accelerates Plans for Real-World Experience Study in the U.S.
20 Sep 2016 VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of Its Preventative Cytomegalovirus Vaccine Candidate
19 Sep 2016 Vical and Astellas Announce Topline Results from a Phase 2 Study of Investigational Cytomegalovirus (CMV) Vaccine (ASP0113) in Kidney Transplant Patients
16 Sep 2016 Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults
16 Sep 2016 GSK’s candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM
13 Sep 2016 Galena Biopharma Presents Preclinical NeuVax™ (nelipepimut-S) Data in Ovarian and Pancreatic Cancer at the Progress in Vaccination Against Cancer (PIVAC) Conference
13 Sep 2016 Prokarium to Develop First Vaccine to Protect Against Sexually Transmitted and Insect-Borne Zika Infections
09 Sep 2016 Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination with Incyte’s IDO1 Enzyme Inhibitor Epacadostat
07 Sep 2016 Moderna Announces Funding Award from BARDA for $8 Million with Potential of up to $125 Million to Accelerate Development of Zika Messenger RNA (mRNA) Vaccine
07 Sep 2016 Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)
07 Sep 2016 Boost vaccination data encourage continued development of Affiris therapeutic Parkinson’s disease vaccine against alpha-synuclein
06 Sep 2016 Themis Bioscience: Zika Vaccine development receives big boost by Innovate UK
02 Sep 2016 Takeda to develop Zika Vaccine with up to $312 million in funding from US Government
01 Sep 2016 Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy
01 Sep 2016 Experts in Dengue Control Form New Alliance to Bridge Vaccine and Vector Approaches and Expand Efforts to Zika and other Aedes-Transmitted Diseases
30 Aug 2016 Hawaii Biotech Awarded Grant To Develop Chikungunya Virus Vaccine
30 Aug 2016 Seqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
30 Aug 2016 Gradalis®, Inc. Announces Dosing of First Patient in Pilot Study Combining Vigil® Engineered Autologous Tumor Cell Immunotherapy and Durvalumab in Advanced Breast Cancer
26 Aug 2016 Immunovaccine Announces Additional Positive Topline Results from Phase 1/1b Clinical Trial Program with DPX-Survivac in Ovarian Cancer
26 Aug 2016 Vaccibody announces positive results from the phase I part of the clinical trial VB C-01 in patients with high-grade cervical dysplasia and recommendation by the cohort review committee as well as the independent data monitoring board to continue to the e
25 Aug 2016 Themis Bioscience: phase 2 trial of leading Chikungunya vaccine candidate started
18 Aug 2016 Xenetic Biosciences Announces Collaboration with Excivion Ltd., UK, to Develop a Novel Combined Zika and Dengue Vaccine
12 Aug 2016 Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top